CardioDx Wins Medicare Coverage of Genetic Test for Heart Disease
07:00 EDT 8 Aug 2012 | Xconomy
CardioDx has spent three years marketing a new genetic test that can tell when a patient’s chest pain is a sign of serious heart disease, or no big cause for alarm. It still has a long way to go before becoming part of mainstream medicine, but now..
Original Article: CardioDx Wins Medicare Coverage of Genetic Test for Heart Disease
More From BioPortfolio on "CardioDx Wins Medicare Coverage of Genetic Test for Heart Disease"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
